Results of Progressive Resistance Training in Older Type 2 Diabetic Patients With Sarcopenia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-80
SponsorNational Geriatric Hospital
About this trial
A randomized controlled clinical trial that will test how progressive resistance training will impact outcomes of sarcopenia in older patients with type 2 diabetes who have been diagnosed as sarcopenia. The intervention will be 12 weeks in duration with approximately 24 sessions of resistance exercises. Outcome measures will be collected at baseline, 4, 8 weeks and 12 weeks.
Eligibility criteria
Qualifiers
Type 2 diabetic patients diagnosed using American Diabetes Association 2022 criteria
HbA1c ≥ 7.0 and ≤ 8.5%
Sarcopenia diagnosed using criteria from the Asian Working Group for Sarcopenia 2019
Age ≥ 60 and ≤ 80
Disqualifiers
Acute diabetic complications
Patients are in the acute phase of musculoskeletal disorders: acute gout, progressing low-grade arthritis, acute joint pain due to joint degeneration, sciatic pain, and infectious arthritis.
Patients suffer from conditions significantly affecting cognition and mobility: sequelae of stroke (with weakness, limb paralysis), muscular weakness, limb disabilities, severe heart failure, severe cognitive decline, and psychiatric disorders.
Patients have been bedridden due to illness for more than 1 month within the past 3 months up to the recruitment time.
Trial design
Treatments tested in this trial
- Progressive Resistance Training
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov